LH supplementation in down-regulated women undergoing assisted reproduction with baseline low serum LH levels

Gynecological Endocrinology

Volumn 26, Issue 2, 2010, Pages 118-124

  Pezzuto, Antonio ^a   Ferrari, Bruno ^a   Coppola, Francesco ^a   Nardelli, Giovanni Battista ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

ART; Down regulated; FF VEGF; LH supplementation

Indexed keywords

ESTROGEN; LEUPRORELIN; LUTEINIZING HORMONE; RECOMBINANT FOLLITROPIN; RECOMBINANT LUTEINIZING HORMONE; VASCULOTROPIN;

ADULT; ARTICLE; CELL MATURATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CUMULUS CELL; DOWN REGULATION; ESTROGEN BLOOD LEVEL; FEMALE; HORMONAL REGULATION; HUMAN; INFERTILITY THERAPY; MAJOR CLINICAL STUDY; OOCYTE; PREGNANCY OUTCOME; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS;

ADULT; DOWN-REGULATION; EMBRYO TRANSFER; ESTRADIOL; FEMALE; FERTILITY AGENTS, FEMALE; FERTILIZATION IN VITRO; FOLLICULAR FLUID; HUMANS; LEUPROLIDE; LUTEINIZING HORMONE; OVULATION INDUCTION; PREGNANCY; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; STATISTICS, NONPARAMETRIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 75449087546     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590903215516     Document Type: Article

References (45)

1. Fevold HL. Synergism of follicle stimulating and luteinizing hormones in producing estrogen secretion. Endocrinology 1941;28:33-36.
2. Greep RO, Van Dyke HB, Chow BF. Gonadotrophin of swine pituitary: various biological effects of FSH and ICSH. Endocrinology 1942;30:635-649.
3. Hillier SG. Gonadotropin control of ovarian follicular growth and development. Molecular and Cellular. Endocrinology 2001;179:39-46.
4. Zeleznik AJ. Follicle selction in primates: 'Many are called but few are chosen'. Biol Reprod 2001;65:655-659.
5. Chappel SC, Howles C. Revaluation of the roles of luteinizing hormone and follicle stimulating hormone in the ovulatory process. Hum Reprod 1996;6:1206-1212.
6. Hillier SG. Current concepts of the roles of follicle stimulating hormone and luteinizing hormone in folliculogenesis. Hum Reprod 1994;9:188-191.
7. Shoham Z. The clinical therapeutic window for luteinizing hormone in controlled ovarian stimulation. Fertil Steril 2002; 77:1170-1177.
8. Levy DP, Navarro JM, Schattman GL, Davis OK, Rosenwaks Z. The role of LH in ovarian stimulation. Exogenous LH: let's design the future. Hum Reprod 2000;15:2258-2265.
9. Balasch J, Fa'bregues F. Is luteinizing hormone needed for optimal ovulation induction? Curr Opin Obstet Gynecol 2002; 14:265-274.
10. Filicori M, Cognigni GE, Samara A, Melappioni S, Perri T, Cantelli B, Parmegiani L, Pelusi G, DeAloysio D. The use of LH activity to drive folliculogenesis: exploring uncharted territories in ovulation induction. Hum Reprod Update 2002;8:543-557.
11. Shoham, Z. The clinical therapeutic window for luteinizing hormone in controlled ovarian stimulation. Fertil Steril 2002; 77:1170-1177.
12. Filicori M, Cognigni GE, Taraborelli S, Spettoli D, Ciampaglia W, Tabarelli F, Pocognoli P. Luteinizing hormone activity supplementation enhances follicle-stimulating hormone efficacy and improves ovulation induction outcome. J Clin Endocrinol Metab 1999;84:2659-2663.
13. Ferraretti AP, Gianaroli L, Magli MC, D'angelo A, Farfalli V, Montanaro N. Exogenous luteinizing hormone in controlled ovarian hyperstimulation for assisted reproduction techniques. Fertility and Sterility 2004; 82:1521-1526.
14. De Placido G, Alviggi C, Mollo A, Strina I, Ranieri A, Alviggi E, Wilding M, VarricchioMT, Borrelli AL, Conforti S. Effects of recombinant LH (rLH) supplementation during controlled ovarian hyperstimulation (COH) in normogonadotrophic women with an initial inadequate response to recombinant FSH (rFSH) after pituitary downregulation. Clin Endocrinol 2004;60:637-643.
15. Westergaard LG, Laursen SB, Andersen CY. Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction. Hum Reprod 2000; 15:1003-1008.
16. Ferrara N, Houck K, Jakeman L, Leung DW. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 1992;13:18-32.
17. Gupta K, Kshirsagar S, LiW, Gui L, Ramakrishna S, Gupta P, Law P, Hebbel RP. VEGF prevents apoptosis of human microvascular endothelial cells via opposing effects on MAPK/ERK and SAPK/JNK signaling. Exp Cell Res 1999;247:495-504.
18. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 1999;13:9-22.
19. Fleming F, Lloyd M, Herbert J, Fenwick T, Griffiths T, Murdoch A. Effects of profound suppression of luteinizing hormone during ovarian stimulation on follicular activity, oocyte and embryo function in cycles stimulated with purified follicle stimulating hormone. Hum Reprod 1998;13:1788-1792.
20. World Health Organization. WHO laboratory manual for the examination of human semen and sperm-cervical mucus interaction. 3rd ed. Cambridge, UK: Cambridge University Press; 1992. pp 1-107.
21. Veeck LL. Oocyte assessment and biological performance. Ann N Y Acad Sci 1988;541:259-274.
22. Klein NA, Battaglia DE, Woodruff TK, Padmanabhan V, Giudice LC, Bremner WJ, Soules MR. Ovarian follicular concentrations of activin, follistatin, inhibin, insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-2 (IGFBP-2), IGFBP-3, and vascular endothelial growth factor in spontaneous menstrual cycles of normal women of advanced reproductive age. J Clin Endocrinol Metab 2000; 85:4520-4525.
23. Friedman CI, Seifer DB, Kennard EA, Arbogast L, Alak BM, Danforth DR. Elevated level of follicular fluid vascular endothelial growth factor is a marker of diminished pregnancy potential. Fertil Steril 1998;70:836-839.
24. Battaglia C, Genazzani AD, Regnani G, Primavera MR, Petraglia F, Volpe A. Perifollicular Doppler flow and follicular fluid vascular endothelial growth factor concentrations in poor responders. Fertil Steril 2000;74:809-812.
25. Ocal P, Aydin S, Cepni I, Idil S, Idil M, Uzun H, Benian A. Follicular fluid concentrations of vascular endothelial growth factor, inhibin A and inhibin B in IVF cycles: are they markers for ovarian response and pregnancy outcome? Eur J Obstet Gynecol Reprod Biol 2004;115:194-199.
26. Friedman CI, Danforth DR, Herbosa-Encarnacion C, Arbogast L, Alak BM, Seifer DB. Follicular fluid vascular endothelial growth factor concentrations are elevated in women of advanced reproductive age undergoing ovulation induction. Fertil Steril 1997;68:607-612.
27. Quintana R, Kopcow L, Marconi G, Sueldo C, Speranza G, Barañao RI. Relationship of ovarian stimulation response with vascular endothelial growth factor and degree of granulosa cell apoptosis. Hum Reprod 2001;16:1814-1818.
28. Barroso G, Barrionuevo M, Rao P, Graham L, Danforth D, Huey S, Abuhamad A, Oehninger S. Vascular endothelial growth factor, nitric oxide, and leptin follicular fluid levels correlate negatively with embryo quality in IVF patients. Fertil Steril 1999;72:1024-1026.
29. Ruvolo G, Bosco L, Pane A, Morici G, Cittadini E, Roccheri MC. Lower apoptosis rate in human cumulus cells after administration of recombinant luteinizing hormone to women undergoing ovarian stimulation for in vitro fertilization procedures. Fertil Steril 2007;87:542-546.
30. Bosco L, Ruvolo G, Morici G, Manno M, Cittadini E, Roccheri MC. Apoptosis in human unfertilized oocytes after intracytoplasmic sperm injection. Fertil Steril 2005;84:1417-1423.
31. Smitz J, Andersen AN, Devroey P, Arce JC; MERIT Group. Endocrine profile in serum and follicular fluid differs after ovarian stimulation with HP-hMG or recombinant FSH in IVF patients Hum Reprod 2007;22:676-1668
32. Ferrai B, Pezzuto A, Barusi L, Coppola F. Gonadotropinreleasing hormone antagonists increase follicular fluid insulinlike growth factor-I and vascular endothelial growth factor during ovarian stimulation cycles. Gynecol Endocrinol 2006; 2:289-296. (Pubitemid 43941405)
33. Ferrai B, Pezzuto A, Barusi L, Coppola F. Follicular fluid vascular endothelial growth factor concentrations are increased during GnRH antagonist/FSH ovarian stimulation cycles. Eur J Obstet Gynecol Reprod Biol 2006;124:70-76.
34. Kobayashi M, Nakano R, Ooshima A. Immunohistochemical localization of pituitary gonadotrophins and gonadal steroids confirms the 'two-cell, two-gonadotrophin' hypothesis of steroidogenesis in the human ovary. J Endocrinol 1990;126: 483-488.
35. Hillier SG, Whitelaw PF, Smyth CD. Follicular oestrogen synthesis: the 'two-cell, two-gonadotrophin' model revisited. Mol Cell Endocrinol 1994;100:51-54.
36. Tesarik J, Mendoza C. Effects of exogenous LH administration during ovarian stimulation of pituitary downregulated young oocyte donors on oocyte yield and developmental competence. Hum Reprod 2002;17:3129-3137.
37. Reilly CM, Cannady WE, Mahesh VB, Stopper VS, De Sevilla LM, Mills TM. Duration of estrogen exposure prior to FSH stimulation critical to granulosa cell growth and differentiation in rats. Biol Reprod 1996;54:1336-1343.
38. Quirk SM, Cowan RG, Harman RM, Hu CL, Poter DA. Ovarian follicular growth and atresia: the relationship between cell proliferation and survival. J Anim Sci 2004;82(E-Suppl): E40-E52. Review.
39. Wu TC, Wang L, Wan YJ. Detection of estrogen receptor messenger ribonucleic acid in human oocytes and cumulusoocyte complexes using reverse transcriptase-polymerase chain reaction. Fertil Steril 1993;59:54-59.
40. Yoshimura Y, Wallach EE. Studies of the mechanism(s) of mammalian ovulation. Fertil Steril 1987;47:22-34.
41. Osbon JC, Moor RM. The role of steroid signals in the maturation of mammalian oocytes. J Steroid Biochem 1983;19:133-138.
42. Panigone S, Hsieh M, Fu M, Persani L, Conti M. Luteinizing hormone signaling in preovulatory follicles involves early activation of the epidermal growth factor receptor pathway. Mol Endocrinol 2008;22:924-1923
43. Tajima K., Orisaka M., Hosokawa K, Amsterdam A, Kotsuji F. Effects of ovarian theca cells on apoptosis and proliferation of granulosa cells: chancing during bovine follicular maturation. Biol Reprod 2002;66:1635-1639.
44. Ashkenazi H, Cao X, Motola S, Popliker M, Conti M, Tsafriri A. Epidermal growth factor family members: endogenous mediators of the ovulatory response. Endocrinology 2005; 146:77-84.
45. Drakakis P, Loutradis D, Kallianidis K, Liapi A, Milingos S. Small doses of LH activity are needed early in ovarian stimulation for better quality oocytes in IVF-ET. Eur J Obstet Gynecol Reprod Biol 2005;121:77-80.